Reporting of adverse reactions to benznidazole: does medical expertise matter?

This study evaluated and compared follow-up and adverse drug reaction (ADR) reporting for Chagas disease (CD) patients treated with benznidazole (BZN) by two health teams with different levels of experience, using medical records for 204 patients participating in the first year of a scaled-up public...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereiro, Ana Cristina, Lenardón, Mabel, Zeballos, Alejandro, Chopita, Marina, Abril, Marcelo, Gold, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Organización Panamericana de la Salud 2018
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385644/
https://www.ncbi.nlm.nih.gov/pubmed/31093097
http://dx.doi.org/10.26633/RPSP.2018.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385644/
https://www.ncbi.nlm.nih.gov/pubmed/31093097
http://dx.doi.org/10.26633/RPSP.2018.69

Ejemplares similares